223 related articles for article (PubMed ID: 28058028)
1. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
Ochenrider MG; Patterson DJ; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
[TBL] [Abstract][Full Text] [Related]
3. Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J
Intern Med J; 2014 Mar; 44(3):287-90. PubMed ID: 24621284
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.
Parakkal D; Sifuentes H; Semer R; Ehrenpreis ED
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1150-6. PubMed ID: 21941193
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
Kotlyar DS; Osterman MT; Diamond RH; Porter D; Blonski WC; Wasik M; Sampat S; Mendizabal M; Lin MV; Lichtenstein GR
Clin Gastroenterol Hepatol; 2011 Jan; 9(1):36-41.e1. PubMed ID: 20888436
[TBL] [Abstract][Full Text] [Related]
6. Pancytopenia in a Young Male Patient With Inflammatory Bowel Disease.
Jansson-Knodell CL; Walker MJ; Fischer M
Gastroenterology; 2021 Apr; 160(5):1483-1485. PubMed ID: 32777287
[No Abstract] [Full Text] [Related]
7. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Thai A; Prindiville T
J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
Moran G; Dillon J; Green J
Inflamm Bowel Dis; 2009 Sep; 15(9):1281-2. PubMed ID: 19067412
[No Abstract] [Full Text] [Related]
9. Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.
Selvaraj SA; Chairez E; Wilson LM; Lazarev M; Bass EB; Hutfless S
Syst Rev; 2013 Jul; 2():53. PubMed ID: 23826928
[TBL] [Abstract][Full Text] [Related]
10. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
[No Abstract] [Full Text] [Related]
11. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic T-Cell Lymphoma: A Rare Complication of Monotherapy with Thiopurines in Crohn's Disease.
Carvão J; Magno Pereira V; Jacinto F; Sousa Andrade C; Jasmins L
GE Port J Gastroenterol; 2019 Jul; 26(4):279-284. PubMed ID: 31328143
[TBL] [Abstract][Full Text] [Related]
13. Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.
Zeidan A; Sham R; Shapiro J; Baratta A; Kouides P
Leuk Lymphoma; 2007 Jul; 48(7):1410-3. PubMed ID: 17613771
[No Abstract] [Full Text] [Related]
14. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.
Shah ED; Coburn ES; Nayyar A; Lee KJ; Koliani-Pace JL; Siegel CA
Aliment Pharmacol Ther; 2020 Mar; 51(5):527-533. PubMed ID: 31990422
[TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic T cell lymphoma: a unifying entity in a patient with hemolytic anemia, massive splenomegaly, and liver dysfunction.
Mavilia M; McAuliffe A; Hafeez S; Vaziri H
Clin J Gastroenterol; 2018 Oct; 11(5):364-370. PubMed ID: 29766398
[TBL] [Abstract][Full Text] [Related]
17. Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis.
Brinkert F; Arrenberg P; Krech T; Grabhorn E; Lohse A; Schramm C
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27516526
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
Drini M; Prichard PJ; Brown GJ; Macrae FA
Med J Aust; 2008 Oct; 189(8):464-5. PubMed ID: 18928444
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN
Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013
[TBL] [Abstract][Full Text] [Related]
20. Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report.
Gasljevic G; Kloboves-Prevodnik V; Gazic B; Vovk M
Diagn Pathol; 2014 Mar; 9():58. PubMed ID: 24621139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
